HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 275 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $436,997 | +77.6% | 8,346 | +35.3% | 0.01% | +62.5% |
| Q1 2022 | $246,000 | -2.4% | 6,170 | -1.6% | 0.01% | +14.3% |
| Q4 2021 | $252,000 | -0.8% | 6,270 | +0.6% | 0.01% | -12.5% |
| Q3 2021 | $254,000 | -10.9% | 6,235 | -0.8% | 0.01% | -11.1% |
| Q2 2021 | $285,000 | -16.2% | 6,285 | -22.9% | 0.01% | -18.2% |
| Q1 2021 | $340,000 | -9.1% | 8,150 | -7.0% | 0.01% | -15.4% |
| Q4 2020 | $374,000 | -38.7% | 8,760 | -62.3% | 0.01% | -43.5% |
| Q3 2020 | $610,000 | – | 23,220 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 14,092,771 | $206,177,000 | 28.12% |
| BB BIOTECH AG | 8,322,860 | $121,763,000 | 3.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 398,633 | $4,579,000 | 2.84% |
| DOHENY ASSET MANAGEMENT /CA | 227,193 | $3,324,000 | 2.43% |
| SNYDER CAPITAL MANAGEMENT L P | 2,833,759 | $41,458,000 | 2.24% |
| First Light Asset Management, LLC | 938,399 | $13,729,000 | 2.19% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,027,164 | $132,067,000 | 1.77% |
| Taylor Wealth Management Partners | 204,277 | $2,989,000 | 1.72% |
| Sterling Global Strategies LLC | 22,000 | $321,860,000 | 1.63% |
| Granite Investment Partners, LLC | 988,939 | $14,468,000 | 1.06% |